We are live on ! Find out more
GIM

Granahan Investment Management Portfolio holdings

AUM $2.07B
1-Year Est. Return 56.45%
This Fund
S&P 500
This Quarter Est. Return
+16.76%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$2.4B
AUM Growth
-$147M
Cap. Flow
-$283M
Cap. Flow %
-11.81%
Top 10 Hldgs %
28.1%
Holding
209
New
22
Increased
53
Reduced
105
Closed
29

Sector Composition

Rank Sector Weight
1 Technology 29.57%
2 Industrials 16.81%
3 Healthcare 15.75%
4 Financials 10.45%
5 Consumer Discretionary 9.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACHC icon
101
Acadia Healthcare
ACHC
$2.96B
$5.64M 0.24%
142,236
+93,346
+191% +$4.21M
NPKI
102
NPK International
NPKI
$1.15B
$5.41M 0.23%
705,707
+21,816
+3% +$160K
DSGX icon
103
Descartes Systems
DSGX
$6.86B
$5.28M 0.22%
46,474
-8,639
-16% -$963K
RVMD icon
104
Revolution Medicines
RVMD
$44.4B
$5.22M 0.22%
119,430
-29,929
-20% -$1.51M
RCUS icon
105
Arcus Biosciences
RCUS
$3.66B
$5.15M 0.22%
346,093
-11,745
-3% -$192K
CLBT icon
106
Cellebrite
CLBT
$3.97B
$5.01M 0.21%
227,397
+93,259
+70% +$1.79M
STVN icon
107
Stevanato
STVN
$5.62B
$4.93M 0.21%
226,401
+110,418
+95% +$2.21M
APLS
108
DELISTED
Apellis Pharmaceuticals
APLS
$4.93M 0.21%
154,418
+3,840
+3% +$115K
MGRC icon
109
McGrath RentCorp
MGRC
$2.94B
$4.64M 0.19%
+41,533
New +$4.76M
ONTO icon
110
Onto Innovation
ONTO
$14.3B
$4.45M 0.19%
26,704
+2,261
+9% +$413K
PSN icon
111
Parsons
PSN
$4.93B
$4.44M 0.19%
48,150
-160,086
-77% -$16.3M
ALGM icon
112
Allegro MicroSystems
ALGM
$7.91B
$4.41M 0.18%
201,817
-81,458
-29% -$1.74M
MRUS
113
DELISTED
Merus
MRUS
$4.4M 0.18%
104,562
-8,689
-8% -$417K
RMBS icon
114
Rambus
RMBS
$10.4B
$4.37M 0.18%
82,620
-24,306
-23% -$1.24M
EEFT icon
115
Euronet Worldwide
EEFT
$2.65B
$4.36M 0.18%
42,412
+9,600
+29% +$977K
DV icon
116
DoubleVerify
DV
$2.03B
$4.26M 0.18%
221,881
+23,149
+12% +$436K
APGE icon
117
Apogee Therapeutics
APGE
$10.2B
$4.21M 0.18%
92,854
+1,097
+1% +$55.9K
RXST icon
118
RxSight
RXST
$273M
$4.13M 0.17%
120,233
+187
+0.2% +$8.43K
IRTC icon
119
iRhythm Holdings
IRTC
$4.11B
$4.12M 0.17%
45,730
-26,698
-37% -$2.1M
UTI icon
120
Universal Technical Institute
UTI
$1.47B
$4.08M 0.17%
158,859
-11,700
-7% -$243K
CIEN icon
121
Ciena
CIEN
$54.9B
$4.02M 0.17%
47,458
-30,778
-39% -$2.21M
OKTA icon
122
Okta
OKTA
$26.2B
$4.01M 0.17%
50,852
+9,823
+24% +$761K
NVMI
123
Nova
NVMI
$12.2B
$3.95M 0.17%
20,068
+2,819
+16% +$542K
AGIO icon
124
Agios Pharmaceuticals
AGIO
$1.95B
$3.8M 0.16%
115,687
-35,098
-23% -$1.65M
NOVT icon
125
Novanta
NOVT
$6.2B
$3.73M 0.16%
24,444
-4,302
-15% -$728K

Similar funds

Granahan Investment Management's Q4 2024 Portfolio in Review

As of Q4 2024, Granahan Investment Management held 209 positions worth $2.4B, down 5.8% from $2.54B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Granahan Investment Management withdrew a net $283M in Q4 2024, closing 29 positions and reducing 105 holdings. Its most notable exit was Smartsheet Inc., an estimated $33.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 33% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Granahan Investment Management opened a new position in KinderCare Learning Companies worth $25.7M.

  • Granahan Investment Management's largest Q4 2024 buy was KinderCare Learning Companies: 1,446,059 shares worth $25.7M.
  • Granahan Investment Management added most to Marex Group Limited Ordinary Shares in Q4 2024, an estimated $26.8M increase.
  • Granahan Investment Management's biggest Q4 2024 reduction was Zeta Global, cutting an estimated $55.8M.
  • Granahan Investment Management fully exited Smartsheet Inc. in Q4 2024, selling an estimated $33.3M.
  • Granahan Investment Management's ten largest holdings make up 28% of its $2.4B portfolio in Q4 2024.
  • Granahan Investment Management opened 22 new positions and closed 29 in Q4 2024.
  • Granahan Investment Management's portfolio value fell 5.8% quarter-over-quarter to $2.4B.

Based on Granahan Investment Management's 13F filing for Q4 2024, filed 14 Feb 2025.